Toxicological safety evaluation of pasteurizedAkkermansia muciniphila

Show full item record



Druart , C , Plovier , H , Van Hul , M , Brient , A , Phipps , K R , Vos , W M & Cani , P D 2021 , ' Toxicological safety evaluation of pasteurizedAkkermansia muciniphila ' , Journal of Applied Toxicology , vol. 41 , no. 2 , pp. 276-290 .

Title: Toxicological safety evaluation of pasteurizedAkkermansia muciniphila
Author: Druart, Celine; Plovier, Hubert; Van Hul, Matthias; Brient, Alizee; Phipps, Kirt R.; Vos, Willem M.; Cani, Patrice D.
Contributor organization: Department of Bacteriology and Immunology
Willem Meindert Vos de / Principal Investigator
de Vos & Salonen group
Research Programs Unit
HUMI - Human Microbiome Research
Faculty of Medicine
University of Helsinki
Date: 2021-02
Language: eng
Number of pages: 15
Belongs to series: Journal of Applied Toxicology
ISSN: 0260-437X
Abstract: Gut microorganisms are vital for many aspects of human health, and the commensal bacteriumAkkermansia muciniphilahas repeatedly been identified as a key component of intestinal microbiota. Reductions inA. muciniphilaabundance are associated with increased prevalence of metabolic disorders such as obesity and type 2 diabetes. It was recently discovered that administration ofA. muciniphilahas beneficial effects and that these are not diminished, but rather enhanced after pasteurization. PasteurizedA. muciniphilais proposed for use as a food ingredient, and was therefore subjected to a nonclinical safety assessment, comprising genotoxicity assays (bacterial reverse mutation and in vitro mammalian cell micronucleus tests) and a 90-day toxicity study. For the latter, Han Wistar rats were administered with the vehicle or pasteurizedA. muciniphilaat doses of 75, 375 or 1500 mg/kg body weight/day (equivalent to 4.8 x 10(9), 2.4 x 10(10), or 9.6 x 10(10)A. muciniphilacells/kg body weight/day) by oral gavage for 90 consecutive days. The study assessed potential effects on clinical observations (including detailed arena observations and a modified Irwin test), body weight, food and water consumption, clinical pathology, organ weights, and macroscopic and microscopic pathology. The results of both in vitro genotoxicity studies were negative. No test item-related adverse effects were observed in the 90-day study; therefore, 1500 mg/kg body weight/day (the highest dose tested, equivalent to 9.6 x 10(10)A. muciniphilacells/kg body weight/day) was established as the no-observed-adverse-effect-level. These results support that pasteurizedA. muciniphilais safe for use as a food ingredient.
Subject: Akkermansia muciniphila
beneficial microorganism
food ingredient
gut microbiota
subchronic toxicity
3111 Biomedicine
Peer reviewed: Yes
Rights: cc_by_nc_nd
Usage restriction: openAccess
Self-archived version: publishedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
jat.4044.pdf 534.7Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record